Abstract
The market for POCT devices can be called labyrinthine – its intricate spectrum of methods spanning from simple test strips to complex immunochemical assays. It therefore makes sense to align a categorization of this technology along the following system characteristics: Sensor characteristics, system complexity, measurement principles, sample matrix and practical benefits.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, et al. (2006) Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care 10:R135
Dark P, Dean P, Warhurst G (2009) Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit Care 13: 1–6
Erhabor O, Richardson G, Mohammed I et al. (2013) Evaluation of the QBC Star centrifugal three-part differential haematology system. Br J Biomed Sci 70: 67–74
Erickson KA, Wilding P (1993) Evaluation of a novel point-of-care system, the i-STAT portable clinical analyzer. Clin Chem 39: 283–287
Ganter MT, Hofer CK (2008) Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 106:1366–1375
Goldmeyer J, Kong H, Tang W (2007) Development of a novel one-tube isothermal reverse transcription thermophilic helicase-dependent amplification platform for rapid RNA detection. J Mol Diagn 9: 639–644
Herrmann S, Vonau W (2004) Online-Analyse mit Lab-on-Chip-Systemen. Technisches Messen 71: 613–618
Liedberg B, Nylander C, Lundstrom I (1995) Biosensing with surface plasmon resonance – how it all started. Biosens Bioelectron 10: i–ix
Lippi G, Favaloro EJ, Plebani M (2011) Direct-to consumer testing: more risks than opportunities. Int J Clin Pract 65:1221–1229
Luppa PB, Müller C, Schlichtiger A, Schlebusch H (2011) Point-of-care testing (POCT): Current techniques and future perspectives. Trends Anal Chem 30: 887–898
Orth M, Luppa PB (2015) Direct-to-Consumer-Testing – Fluch oder Segen für die Patienten? Dtsch Ärztebl 112: A174–A176
Piepenburg O, Williams C, Stemple D, Armes N (2006) DNA detection using recombination proteins. PLoS Biol 4: e204
Seme K, Mocilnik T, Komlos KF, Doplihar A, Persing DH, Poljak M (2008) GeneXpert enterovirus assay: one-year experience in a routine laboratory setting and evaluation on three proficiency panels. J Clin Microbiol 46: 1510–1513
Spindel S, Sapsford K (2014) Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use. Sensors (Basel) 14: 22313–22341
St John A (2004) Benchtop Instruments for Point-of-care Testing. In: Price CP, St John A, Hicks JM (eds) Point-of-care Testing, 2nd ed. AACC Press, Washington, pp 31–46
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Germany, part of Springer Nature
About this chapter
Cite this chapter
Luppa, P.B. (2018). Device classes. In: Luppa, P.B., Junker, R. (eds) Point-of-Care Testing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54497-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-54497-6_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54496-9
Online ISBN: 978-3-662-54497-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)